LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Other Current Liabilities
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Increase (Decrease) in Other Current Liabilities of -$4.08 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2022-02-28
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for the quarter ending 2021-03-31 was -$3.77M, a 7636.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for the quarter ending 2020-12-31 was -$3.81M, a 524.19% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for the quarter ending 2020-09-30 was -$2.67M, a 228.50% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for the quarter ending 2020-06-30 was $3.09M, a 250.74% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for fiscal 2021 was -$4.08M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for fiscal 2020 was -$3.34M, a 193.40% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for fiscal 2019 was $3.58M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other current liabilities for fiscal 2018 was -$4.30M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 3 month as first filed | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 9 month as first filed | Increase (Decrease) in Other Current Liabilities 12 month | Increase (Decrease) in Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$4.08M 10-K · filed 2022-02-28 | ||||||
| 2021-03-31 | -$3.77M 10-Q · filed 2021-05-06 | -$7.57M derived: sum of 2 quarters · filed 2022-02-28 | -$10.25M derived: sum of 3 quarters · filed 2022-02-28 | -$7.16M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$6.48M derived: sum of 2 quarters · filed 2022-02-28 | -$3.39M derived: sum of 3 quarters · filed 2022-02-28 | -$3.34M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $416.00K derived: sum of 2 quarters · filed 2020-11-06 | $466.00K 10-Q · filed 2020-11-06 | $1.36M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.14M 10-Q · filed 2020-08-07 | $4.04M derived: sum of 3 quarters · filed 2022-02-28 | $6.12M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-06 | $2.27M 10-Q · filed 2020-05-08 | $947.00K derived: sum of 2 quarters · filed 2022-02-28 | $3.03M derived: sum of 3 quarters · filed 2022-02-28 | $3.91M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.98M derived: sum of 2 quarters · filed 2022-02-28 | $3.86M derived: sum of 3 quarters · filed 2022-02-28 | $3.58M 10-K · filed 2022-02-28 | $2.43M 10-K · filed 2020-02-27 | ||
| 2019-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.96M derived: sum of 2 quarters · filed 2020-11-06 | $2.68M 10-Q · filed 2020-11-06 | $2.98M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $597.00K 10-Q · filed 2020-08-07 | $899.00K derived: sum of 3 quarters · filed 2021-02-24 | -$3.11M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$284.00K 10-Q · filed 2020-05-08 | -$4.12M 10-Q · filed 2019-05-09 | $18.00K derived: sum of 2 quarters · filed 2021-02-24 | -$3.99M derived: sum of 3 quarters · filed 2021-02-24 | -$4.06M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$3.71M derived: sum of 2 quarters · filed 2021-02-24 | -$3.78M derived: sum of 3 quarters · filed 2021-02-24 | -$4.30M 10-K · filed 2021-02-24 | -$5.46M 10-K · filed 2020-02-27 | ||
| 2018-09-30 | -$4.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$4.08M derived: sum of 2 quarters · filed 2019-11-08 | -$4.60M 10-Q · filed 2019-11-08 | -$3.87M 10-Q · filed 2018-11-08 | -$4.67M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$594.00K 10-Q · filed 2019-08-08 | -$658.00K derived: sum of 3 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$522.00K 10-Q · filed 2019-05-09 | -$586.00K derived: sum of 2 quarters · filed 2020-02-27 | |||||
| 2017-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$5.06M 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | -$5.00M 10-Q · filed 2018-11-08 |